Post-transcriptional control of cytokine gene expression in health and disease

Journal of Interferon and Cytokine Research

Volumn 34, Issue 4, 2014, Pages 215-219

  Khabar, Khalid S A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR; 3' UNTRANSLATED REGION; AUTACOID; MICRORNA; RNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN;

APOPTOSIS; AU RICH ELEMENT; CELL ACTIVATION; CELL CYCLE PROGRESSION; CELL GROWTH; GENE EXPRESSION; GU RICH ELEMENT; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; POSTTRANSCRIPTION REGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA PROCESSING; RNA STRUCTURE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS ENTRY; VIRUS REPLICATION; 3' UNTRANSLATED REGION; ANIMAL; GENETICS; IMMUNOLOGY; IMMUNOPATHOLOGY; METABOLISM; NEOPLASM;

3' UNTRANSLATED REGIONS; ANIMALS; AU RICH ELEMENTS; CYTOKINES; GENE EXPRESSION; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION MEDIATORS; MICRORNAS; NEOPLASMS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA-BINDING PROTEINS; TRANS-ACTIVATORS;

EID: 84898722252     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0151     Document Type: Review

References (46)

1. Al-Ahmadi W, Al-Ghamdi M, Al-Haj L, Al-Saif M, Khabar KS. 2009. Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. Nucleic Acids Res 37(11):3612-3624.
2. Al-Ahmadi W, Al-Ghamdi M, Al-Souhibani N, Khabar KS. 2013. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer. J Pathol 230(1):28-38.
3. Al-Souhibani N, Al-Ahmadi W, Hesketh JE, Blackshear PJ, Khabar KS. 2010. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. Oncogene 29(29):4205-4215.
4. Blackshear PJ, Perera L. 2014. Phylogenetic distribution and evolution of the linked RNA binding and NOT1 binding domains in the TTP family of tandem CCCH zinc finger proteins. J Interferon Cytokine Res 34(4):297-306.
5. Bourcier C, Griseri P, Grepin R, Bertolotto C, Mazure N, Pages G. 2011. Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells. Am J Physiol Cell Physiol 301(3):C609-C618.
6. Brennan-Laun SE, Ezelle HJ, Li X-L, Hassel BA. 2014. RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting. J Interferon Cytokine Res 34(4):275-288.
7. Brennan SE, Kuwano Y, Alkharouf N, Blackshear PJ, Gorospe M, Wilson GM. 2009. The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res 69(12):5168-5176.
8. Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA. 2010. The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand J Immunol 71(5):382-385.
9. Clement SL, Scheckel C, Stoecklin G, Lykke-Andersen J. 2011. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Mol Cell Biol 31(2):256-266.
10. Gebeshuber CA, Zatloukal K, Martinez J. 2009. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 10(4):400-405.
11. Ghosh S, Hoenerhoff MJ, Clayton N, Myers P, Stumpo DJ, Maronpot RR, Blackshear PJ. 2010. Left-sided cardiac valvulitis in tristetraprolin-deficient mice: the role of tumor necrosis factor alpha. Am J Pathol 176(3):1484-1493.
12. Griseri P, Pagès G. 2014. Control of pro-angiogenic cytokine mRNA half-life in cancer: the role of AU-rich elements and associated proteins. J Interferon Cytokine Res 34(4): 242-254.
13. Halees AS, Hitti E, Al-Saif M, Mahmoud L, Vlasova-St Louis IA, Beisang DJ, Bohjanen PR, Khabar K. 2011. Global assessment of GU-rich regulatory content and function in the human transcriptome. RNA Biol 8(4):681-691.
14. Hamilton T, Li X, Novotny M, Pavicic PG, Jr., Datta S, Zhao C, Hartupee J, Sun D. 2012. Cell type-and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression. J Leukoc Biol 91(3):377-383.
15. He M, Xu Z, Ding T, Kuang DM, Zheng L. 2009. MicroRNA-155 regulates inflammatory cytokine production in tumorassociated macrophages via targeting C/EBPbeta. Cell Mol Immunol 6(5):343-352.
16. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M. 2006. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol 26(6):2399-2407.
17. Jafarifar F, Yao P, Eswarappa SM, Fox PL. 2011. Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J 30(7):1324-1334.
18. Kanies CL, Smith JJ, Kis C, Schmidt C, Levy S, Khabar KS, Morrow J, Deane N, Dixon DA, Beauchamp RD. 2008. Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition. Mol Cancer Res 6(7):1124-1136.
19. Khabar KS. 2010. Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell Mol Life Sci 67(17):2937-2955.
20. Khabar KS, Bakheet T, Williams BR. 2005. AU-rich transient response transcripts in the human genome: expressed sequence tag clustering and gene discovery approach. Genomics 85(2):165-175.
21. Khabar KS, Siddiqui YM, al-Zoghaibi F, al-Haj L, Dhalla M, Zhou A, Dong B, Whitmore M, Paranjape J, Al-Ahdal MN, Al-Mohanna F, Williams BR, Silverman RH. 2003. RNase L mediates transient control of the interferon response through modulation of the double-stranded RNA-dependent protein kinase PKR. J Biol Chem 278(22):20124-20132.
22. Khabar KS, Young HA. 2007. Post-transcriptional control of the interferon system. Biochimie 89(6-7):761-769.
23. Kim CW, Vo MT, Kim HK, Lee HH, Yoon NA, Lee BJ, Min YJ, Joo WD, Cha HJ, Park JW, Cho WJ. 2012. Ectopic overexpression of tristetraprolin in human cancer cells promotes biogenesis of let-7 by down-regulation of Lin28. Nucleic Acids Res 40(9):3856-3869.
24. King PH, Chen C-Y. 2014. Role of KSRP in control of type I interferon and cytokine expression. J Interferon Cytokine Res 34(4):267-274.
25. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10(3):387-398.
26. Lu JY, Sadri N, Schneider RJ. 2006. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes Dev 20(22):3174-3184.
27. Mayr C, Bartel DP. 2009. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138(4):673-684.
28. Mazumder B, Li X, Barik S. 2010. Translation control: a multifaceted regulator of inflammatory response. J Immunol 184(7):3311-3319.
29. Milke L, Schulz K, Weigert A, ShaW, Schmid T, Brune B. 2013. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages. Carcinogenesis 34(4):850-857.
30. Panganiban RP, Vonakis B, Ishmael FT, Stellato C. 2014. Coordinated posttranscriptional regulation of the chemokine system: messages from CCL2. J Interferon Cytokine Res 34(4):255-266.
31. Patil CS, Liu M, Zhao W, Coatney DD, Li F, VanTubergen EA, D'Silva NJ, Kirkwood KL. 2008. Targeting mRNA stability arrests inflammatory bone loss. Mol Ther 16(10): 1657-1664.
32. Paulsen MT, Veloso A, Prasad J, Bedi K, Ljungman EA, Tsan YC, Chang CW, Tarrier B, Washburn JG, Lyons R, Robinson DR, Kumar-Sinha C, Wilson TE, Ljungman M. 2013. Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response. Proc Natl Acad Sci USA 110(6):2240-2245.
33. Phillips K, Kedersha N, Shen L, Blackshear PJ, Anderson P. 2004. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proc Natl Acad Sci USA 101(7):2011-2016.
34. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB. 2008. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 320(5883):1643-1647.
35. Simone LE, Keene JD. 2013. Mechanisms coordinating ELAV/Hu mRNA regulons. Curr Opin Genet Dev 23(1):35-43.
36. Srikantan S, Gorospe M. 2012. HuR function in disease. Front Biosci (Landmark Ed) 17:189-205.
37. Suzuki T, Tsutsumi A, Suzuki H, Suzuki E, Sugihara M, Muraki Y, Hayashi T, Chino Y, Goto D, Matsumoto I, Ito S, Miyazawa K, Sumida T. 2008. Tristetraprolin (TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals. Mod Rheumatol 18(5):472-479.
38. Tanaka Y. 2013. Next stage of RA treatment: is TNF inhibitorfree remission a possible treatment goal? Ann Rheum Dis 72 Suppl 2:ii124-ii127.
39. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ. 1996. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4(5):445-454.
40. Tiedje C, Holtmann H, Gaestel M. 2014. The role of mammalian MAPK signaling in regulation of cytokine mRNA stability and translation. J Interferon Cytokine Res 34(4): 220-232.
41. Touriol C, Morillon A, Gensac MC, Prats H, Prats AC. 1999. Expression of human fibroblast growth factor 2 mRNA is post-transcriptionally controlled by a unique destabilizing element present in the 3'-untranslated region between alternative polyadenylation sites. J Biol Chem 274(30):21402-21408.
42. Upadhyay R, Sanduja S, Kaza V, Dixon DA. 2013. Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival. Int J Cancer 132(3):E128-E138.
43. Vlasova-St. Louis I, Bohjanen PR. 2014. Posttranscriptional regulation of cytokine signaling by AU-rich and GU-rich elements. J Interferon Cytokine Res 34(4):233-241.
44. Xie Y-F, Shu R, Jiang S-Y, Liu D-L, Ni J, Zhang X-L. 2013. MicroRNA-146 inhibits pro-inflammatory cytokine secretion through IL-1 receptor-associated kinase 1 in human gingival fibroblasts. J Inflamm 10(1):20.
45. Young LE, Sanduja S, Bemis-Standoli K, Pena EA, Price RL, Dixon DA. 2009. The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology 136(5):1669-1679.
46. Zwerina J, Hayer S, Redlich K, Bobacz K, Kollias G, Smolen JS, Schett G. 2006. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction. Arthritis Rheum 54(2):463-472.